Established and suggested exposures on CLL/SLL etiology: Results from the CLL-MCC-Spain study.

[1]  S. Swerdlow.  WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues , 2017 .

[2]  B. Nordestgaard,et al.  High alcohol consumption causes high IgE levels but not high risk of allergic disease. , 2016, The Journal of allergy and clinical immunology.

[3]  Paolo Vineis,et al.  Meta-analysis of genome-wide association studies discovers multiple loci for chronic lymphocytic leukemia , 2016, Nature Communications.

[4]  Vicente Martín,et al.  Population-based multicase-control study in common tumors in Spain (MCC-Spain): rationale and study design. , 2015, Gaceta sanitaria.

[5]  E. Riboli,et al.  Prediagnostic immunoglobulin E levels and risk of chronic lymphocytic leukemia, other lymphomas and multiple myeloma-results of the European Prospective Investigation into Cancer and Nutrition. , 2014, Carcinogenesis.

[6]  J. Cerhan,et al.  Medical history, lifestyle, family history, and occupational risk factors for chronic lymphocytic leukemia/small lymphocytic lymphoma: the InterLymph Non-Hodgkin Lymphoma Subtypes Project. , 2014, Journal of the National Cancer Institute. Monographs.

[7]  Bernd Holleczek,et al.  Survival for haematological malignancies in Europe between 1997 and 2008 by region and age: results of EUROCARE-5, a population-based study. , 2014, The Lancet. Oncology.

[8]  C. la Vecchia,et al.  Alcohol drinking and risk of leukemia-a systematic review and meta-analysis of the dose-risk relation. , 2014, Cancer epidemiology.

[9]  Jennifer R. Brown.  Inherited susceptibility to chronic lymphocytic leukemia: evidence and prospects for the future , 2013, Therapeutic advances in hematology.

[10]  F. Clavel-Chapelon,et al.  Anthropometric characteristics and risk of lymphoid and myeloid leukemia in the European Prospective Investigation into Cancer and Nutrition (EPIC) , 2013, Cancer Causes & Control.

[11]  S. de Sanjosé,et al.  Common Infectious Agents and Monoclonal B-Cell Lymphocytosis: A Cross-Sectional Epidemiological Study among Healthy Adults , 2012, PloS one.

[12]  J. Cerhan,et al.  Self‐reported history of infections and the risk of non‐Hodgkin lymphoma: An InterLymph pooled analysis , 2012, International journal of cancer.

[13]  J. Mitri,et al.  Obesity but not overweight increases the incidence and mortality of leukemia in adults: a meta-analysis of prospective cohort studies. , 2012, Leukemia research.

[14]  Celine M Vachon,et al.  Genome-wide association study identifies a novel susceptibility locus at 6p21.3 among familial CLL. , 2011, Blood.

[15]  R. Goldbohm,et al.  Body mass index, height, and risk of lymphatic malignancies: a prospective cohort study. , 2009, American journal of epidemiology.

[16]  M. Björkholm,et al.  Elevated risk of chronic lymphocytic leukemia and other indolent non-Hodgkin’s lymphomas among relatives of patients with chronic lymphocytic leukemia , 2009, Haematologica.

[17]  S. Sanjosé,et al.  Medical history and risk of lymphoma: results of a European case–control study (EPILYMPH) , 2009, Journal of Cancer Research and Clinical Oncology.

[18]  E. Riboli,et al.  Diabetes and the risk of non-Hodgkin’s lymphoma and multiple myeloma in the European Prospective Investigation into Cancer and Nutrition , 2008, Haematologica.

[19]  D. Weisenburger,et al.  Non‐Hodgkin lymphoma and obesity: A pooled analysis from the InterLymph Consortium , 2007, International journal of cancer.

[20]  S. Larsson,et al.  Obesity and risk of non‐Hodgkin's lymphoma: A meta‐analysis , 2007, International journal of cancer.

[21]  M. Kogevinas,et al.  Immunoglobulin E Levels and Risk of Lymphoma in a Case-Control Study in Spain , 2007, Cancer Epidemiology Biomarkers & Prevention.

[22]  N. Caporaso,et al.  Respiratory tract infections and subsequent risk of chronic lymphocytic leukemia. , 2007, Blood.

[23]  D. Weisenburger,et al.  Family history of hematopoietic malignancies and risk of non-Hodgkin lymphoma (NHL): a pooled analysis of 10 211 cases and 11 905 controls from the International Lymphoma Epidemiology Consortium (InterLymph). , 2006, Blood.

[24]  S. de Sanjosé,et al.  Type 2 diabetes mellitus, its treatment and risk for lymphoma. , 2005, European journal of cancer.

[25]  J. Cerhan,et al.  Anthropometric characteristics, physical activity, and risk of non-Hodgkin's lymphoma subtypes and B-cell chronic lymphocytic leukemia: a prospective study. , 2002, American journal of epidemiology.

[26]  T. Marrie.  Pneumococcal pneumonia: epidemiology and clinical features. , 1999, Seminars in respiratory infections.

[27]  S. Slager,et al.  Familial CLL: genes and environment. , 2007, Hematology. American Society of Hematology. Education Program.